Table 2 General information statistics
Total (105) | CRAB (68) | CSAB (37) | ||
|---|---|---|---|---|
Gender (male,%) | 58 (55.2) | 39 (57.3) | 19 (51.4) | |
Age (m) | 27 (6, 60) | 32 (7, 60) | 24 (4, 72) | P = 0.497 |
Specimen source (%) | ||||
Sputum | 75 (71.4) | 47 (69.1) | 28 (75.7) | |
Endotracheal tube | 16 (15.2) | 14 (20.5) | 2 (5.4) | |
Alveolar lavage fluid | 7 (6.7) | 5 (7.3) | 2 (5.4) | |
Others | 7 (6.7) | 2 (2.8) | 5 (13.5) | |
PELOD2 score (Admitted within 24 h), M (IQR) | 2 (0, 5) | 3 (0, 5) | 2 (1, 3) | P = 0.17 |
Primary disease was infectious or not | ||||
Yes | 81 (77.1) | 51 (75.0) | 30 (81.1) | P = 0.628 |
No | 24 (22.9) | 17 (25.0) | 7 (18.9) | |
Classification of primary disease (%) | ||||
Pulmonary infection | 58 (55.2) | 33 (48.5) | 25 (67.6) | |
Intracranial infection | 16 (15.2) | 12 (17.6) | 4 (10.8) | |
Sepsis | 8 (7.6) | 6 (8.8) | 2 (5.4) | |
Trauma | 11 (10.5) | 10 (14.7) | 1 (2.7) | |
Others | 12 (11.4) | 7 (10.3) | 5 (13.5) | |
Underlying disease | ||||
Yes | 52 (49.5) | 33 (48.5) | 19 (51.4) | P = 0.84 |
No | 53 (50.5) | 35 (51.5) | 18 (48.6) | |
Classification of underlying diseases (%) | ||||
Heart diseases | 18 (17.1) | 12 (17.6) | 6 (16.2) | |
Muscle diseases | 12 (11.4) | 6 (8.8) | 6 (16.2) | |
Metabolic diseases | 5 (4.8) | 5 (7.4) | 0 | |
Respiratory malformation | 5 (4.8) | 4 (5.9) | 1 (2.7) | |
Blood diseases and tumors | 5 (4.8) | 3 (4.4) | 2 (5.4) | |
Multiple malformations | 5 (4.8) | 4 (5.9) | 1 (2.7) | |
Other invasive operations (%) | ||||
Deep vein catheterization | 40 (38.1) | 34 (50) | 6 (16.2) | |
Bronchonscope | 18 (17.1) | 14 (20.6) | 4 (10.8) | |
CRRT | 11 (10.5) | 7 (10.3) | 4 (10.8) | |
Thoracocentesis | 19 (18.1) | 15 (22.1) | 4 (10.8) | |
Peritonrocentesis | 2 (2.0) | 2 (2.9) | 0 | |
Catheterization | 63 (60.0) | 46 (67.6) | 17 (45.9) | |
Surgery | 28 (26.7) | 21 (30.9) | 7 (18.9) | |
Total mechanical ventilation time (h), M (IQR) | 94 (1, 270) | 215 (119.5, 370.5) | 136 (64, 300) | P = 0.035 |
Total antibiotic use time (d), M (IQR) | 22 (18, 31) | 22.5 (17, 34) | 22 (18, 26) | P = 0.207 |
Total hospital stay (d), M (IQR) | 39 (22, 64) | 41 (24, 59) | 35 (19, 64) | P = 0.487 |
Major tests within 48 h of Ab positive, M (IQR) | ||||
WBC (109/L) | 10.6 (7.3, 14.6) | 9.5 (6.5, 14.4) | 11.1 (8.5, 16.7) | P = 0.145 |
CRP (mg/L) | 16.8 (6.3, 68.7) | 17.8 (7.5, 75.3) | 14.2 (5.1, 51.6) | P = 0.388 |
PCT (ng/ml) | 1.0 (0.3, 6.2) | 1.4 (0.3, 6.2) | 0.7 (0.3, 3.4) | P = 0.544 |
Hb (g/L) | 92 (82, 105) | 92 (82, 104) | 91 (83.5, 104) | P = 0.817 |
PLT (109/L) | 266.5 (133.5, 430.5) | 261 (127, 435) | 306 (156.9, 408) | P = 0.58 |
Mechanical ventilation time after Ab positive (h), M (IQR) | 94 (24, 245) | 62 (23.5, 268) | 112 (24, 220) | P = 0.936 |
Antibiotic use time after Ab positive (d), M (IQR) | 10 (5, 19) | 11.5 (5.5, 23.5) | 8 (5, 12) | P = 0.043 |
Length of hospital stay after Ab positive (d), M (IQR) | 21 (10, 39) | 20.5 (8.5.39) | 26 (13, 38) | P = 0.407 |
Outcome | ||||
Survive | 78 (74.3) | 48 (70.6) | 28 (75.7) | P = 0.652 |
Dead | 29 (25.7) | 20 (29.4) | 9 (24.3) |